Source:http://linkedlifedata.com/resource/pubmed/id/21393064
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2011-3-25
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1474-4465
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
291-3
|
| pubmed:meshHeading | |
| pubmed:year |
2011
|
| pubmed:articleTitle |
Ascorbic acid for treatment in CMT1A: what's next?
|
| pubmed:affiliation |
Department of Neurology, Academic Medical Centre, 1100 DD Amsterdam, Netherlands. m.devisser@amc.nl
|
| pubmed:publicationType |
Journal Article,
Comment
|